Title:
Genomics Market Research Report: By Solution (Consumables, Instruments, Services), Technology (PCR, Sequencing, Microarray), Application (Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture and Animal Research), End User (Research Centers and Academic Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies) - Global Industry Analysis and Growth Forecast to 2030.
According to a study conducted by P&S Intelligence, the global genomics market is expected to generate a revenue of $68.0 billion by 2030, increasing from $18.2 billion in 2019, progressing at a 12.7% CAGR during the forecast period (2020-2030).
The market is growing due to the increasing government initiatives and support, rising requirement for personalized medicine, and reduction in the cost of sequencing services. In terms of solution, the market is categorized into services, consumables, and instruments, among which, the consumables category dominated the market in 2019.
This can be attributed to the rising number of samples that are being processed at labs, research centers, and several other end-use settings. In addition to this, the growing number of research projects are also resulting in the rising demand for consumables. On the basis of application, the genomics market is categorized into diagnostics, agriculture and animal research, precision medicine, and drug discovery & development. Among which, the diagnostics category held the major share of the market in 2019, owing to the rising research projects related to genetic diseases, including cancer.
When technology is taken into consideration, the genomics market is classified into microarray, polymerase chain reaction, and sequencing, out of which, the sequencing classification is predicted to witness the highest CAGR during the forecast period. The demand for this technology is growing rapidly, owing to its lowering cost. As per the National Human Genome research Institute, the cost of genome sequencing was about $10,000 in the mid-2011, which decreased considerably to $1,000 in 2018. This is expected to drive the adoption of sequencing, thereby leading to the growth of the market.
North America accounted for the largest share of the market in the past, which is because of the various ongoing genomics research projects, presence of major players, and increasing investments in the industry by both government and private organizations. The Asia-Pacific region is predicted to register the highest CAGR during the forecast period, as the number of research activities in the field to genomics is growing in countries including Japan, India, and China. Both public and private organizations are providing funding for innovations in genome research.
In conclusion, the market is being driven by increasing need for personalized medicine and rising support and initiatives by governments across the globe.
Table of Contents
Chapter 1. Research Background
- 1.1 Research Objectives
- 1.2 Market Definition
- 1.3 Research Scope
- 1.3.1 Market Segmentation by Solution
- 1.3.2 Market Segmentation by Technology
- 1.3.3 Market Segmentation by Application
- 1.3.4 Market Segmentation by End User
- 1.3.5 Market Segmentation by Region
- 1.3.6 Analysis Period
- 1.3.7 Market Data Reporting Unit
- 1.4 Key Stakeholders
Chapter 2. Research Methodology
- 2.1 Secondary Research
- 2.2 Primary Research
- 2.2.1 Split of Primary Research Information
- 2.2.2 Breakdown of Primary Research Respondents
- 2.2.2.1 By industry participant
- 2.2.2.2 By company type
- 2.2.3 Breakdown of Primary Research by Company and Designation
- 2.3 Baseline Methodology
- 2.4 Market Size Estimation
- 2.5 Data Triangulation
- 2.6 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
- 4.1 Definition of Market Segments
- 4.1.1 By Solution
- 4.1.1.1 Consumables
- 4.1.1.2 Instruments
- 4.1.1.3 Services
- 4.1.2 By Technology
- 4.1.2.1 PCR
- 4.1.2.2 Sequencing
- 4.1.2.3 Microarray
- 4.1.2.4 Others
- 4.1.3 By Application
- 4.1.3.1 Diagnostics
- 4.1.3.2 Drug discovery and development
- 4.1.3.3 Precision medicine
- 4.1.3.4 Agriculture and animal research
- 4.1.3.5 Others
- 4.1.4 By End User
- 4.1.4.1 Research centers and academic institutes
- 4.1.4.2 Hospitals and clinics
- 4.1.4.3 Pharmaceutical and biotechnology companies
- 4.1.4.4 Others
- 4.2 Market Dynamics
- 4.2.1 Trends
- 4.2.1.1 Increasing number of acquisitions
- 4.2.1.2 Growing partnerships among market players
- 4.2.2 Drivers
- 4.2.2.1 Rising government support and initiatives
- 4.2.2.2 Reducing cost of sequencing services
- 4.2.2.3 Growing demand for personalized medicines
- 4.2.2.4 Impact analysis of drivers on market forecast
- 4.2.3 Restraints
- 4.2.3.1 Data privacy concerns
- 4.2.3.2 High data storage requirements
- 4.2.3.3 Impact analysis of restraints on market forecast
- 4.2.4 Opportunities
- 4.2.4.1 Potential to cure previously incurable diseases
- 4.3 Impact of COVID-19
- 4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Buyers
- 4.4.2 Bargaining Power of Suppliers
- 4.4.3 Intensity of Rivalry
- 4.4.4 Threat of New Entrants
- 4.4.5 Threat of Substitutes
Chapter 5. Global Market Size and Forecast
- 5.1 By Solution
- 5.2 By Technology
- 5.3 By Application
- 5.4 By End User
- 5.5 By Region
Chapter 6. North America Market Size and Forecast
- 6.1 Overview
- 6.2 By Solution
- 6.3 By Technology
- 6.4 By Application
- 6.5 By End User
- 6.6 By Country
- 6.6.1 U.S. Market Size and Forecast
- 6.6.1.1 By solution
- 6.6.1.2 By technology
- 6.6.2 Canada Market Size and Forecast
- 6.6.2.1 By solution
- 6.6.2.2 By technology
Chapter 7. Europe Market Size and Forecast
- 7.1 Overview
- 7.2 By Solution
- 7.3 By Technology
- 7.4 By Application
- 7.5 By End User
- 7.6 By Country
- 7.6.1 U.K. Market Size and Forecast
- 7.6.1.1 By solution
- 7.6.1.2 By technology
- 7.6.2 Germany Market Size and Forecast
- 7.6.2.1 By solution
- 7.6.2.2 By technology
- 7.6.3 France Market Size and Forecast
- 7.6.3.1 By solution
- 7.6.3.2 By technology
- 7.6.4 Italy Market Size and Forecast
- 7.6.4.1 By solution
- 7.6.4.2 By technology
- 7.6.5 Spain Market Size and Forecast
- 7.6.5.1 By solution
- 7.6.5.2 By technology
Chapter 8. APAC Market Size and Forecast
- 8.1 Overview
- 8.2 By Solution
- 8.3 By Technology
- 8.4 By Application
- 8.5 By End User
- 8.6 By Country
- 8.6.1 China Market Size and Forecast
- 8.6.1.1 By solution
- 8.6.1.2 By technology
- 8.6.2 Japan Market Size and Forecast
- 8.6.2.1 By solution
- 8.6.2.2 By technology
- 8.6.3 India Market Size and Forecast
- 8.6.3.1 By solution
- 8.6.3.2 By technology
Chapter 9. LATAM Market Size and Forecast
- 9.1 Overview
- 9.2 By Solution
- 9.3 By Technology
- 9.4 By Application
- 9.5 By End User
- 9.6 By Country
Chapter 10. MEA Market Size and Forecast
- 10.1 Overview
- 10.2 By Solution
- 10.3 By Technology
- 10.4 By Application
- 10.5 By End User
- 10.6 By Country
Chapter 11. Competitive Landscape
- 11.1 List of Players and Their Offerings
- 11.2 Competitive Benchmarking of Key Players
- 11.3 Strategic Developments in the Market
- 11.3.1 Mergers and Acquisitions
- 11.3.2 Product and Service Launches
- 11.3.3 Partnerships
- 11.3.4 Other Developments
Chapter 12. Company Profiles
- 12.1 Bio-Rad Laboratories Inc.
- 12.1.1 Business Overview
- 12.1.2 Product and Service Offerings
- 12.1.3 Key Financial Summary
- 12.2 Agilent Technologies Inc.
- 12.2.1 Business Overview
- 12.2.2 Product and Service Offerings
- 12.2.3 Key Financial Summary
- 12.3 Quest Diagnostics Inc.
- 12.3.1 Business Overview
- 12.3.2 Product and Service Offerings
- 12.3.3 Key Financial Summary
- 12.4 Danaher Corporation
- 12.4.1 Business Overview
- 12.4.2 Product and Service Offerings
- 12.4.3 Key Financial Summary
- 12.5 QIAGEN N.V.
- 12.5.1 Business Overview
- 12.5.2 Product and Service Offerings
- 12.5.3 Key Financial Summary
- 12.6 F. Hoffmann-La Roche Ltd.
- 12.6.1 Business Overview
- 12.6.2 Product and Service Offerings
- 12.6.3 Key Financial Summary
- 12.7 Eurofins Scientific SE
- 12.7.1 Business Overview
- 12.7.2 Product and Service Offerings
- 12.7.3 Key Financial Summary
- 12.8 Pacific Biosciences of California Inc.
- 12.8.1 Business Overview
- 12.8.2 Product and Service Offerings
- 12.8.3 Key Financial Summary
- 12.9 GENEWIZ Inc.
- 12.9.1 Business Overview
- 12.9.2 Product and Service Offerings
- 12.10 Psomagen Inc.
- 12.10.1 Business Overview
- 12.10.2 Product and Service Offerings
- 12.11 BGI Tech Solutions Co. Ltd.
- 12.11.1 Business Overview
- 12.11.2 Product and Service Offerings
- 12.12 Oxford Nanopore Technologies Ltd.
- 12.12.1 Business Overview
- 12.12.2 Product and Service Offerings
- 12.13 10X Genomics Inc.
- 12.13.1 Business Overview
- 12.13.2 Product and Service Offerings
- 12.13.3 Key Financial Summary
- 12.14 Eppendorf AG
- 12.14.1 Business Overview
- 12.14.2 Product and Service Offerings
- 12.14.3 Key Financial Summary
- 12.15 Thermo Fisher Scientific Inc.
- 12.15.1 Business Overview
- 12.15.2 Product and Service Offerings
- 12.15.3 Key Financial Summary
- 12.16 Illumina Inc.
- 12.16.1 Business Overview
- 12.16.2 Product and Service Offerings
- 12.16.3 Key Financial Summary
Chapter 13. Appendix
- 13.1 Abbreviations
- 13.2 Sources and References
- 13.3 Related Reports
List of Tables
- TABLE 1 ANALYSIS PERIOD OF THE STUDY
- TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
- TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
- TABLE 4 COVID-19 IMPACT ANALYSIS ON DIFFERENT SECTORS
- TABLE 5 GLOBAL GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 6 GLOBAL GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 7 GLOBAL GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 8 GLOBAL GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 9 GLOBAL GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
- TABLE 10 GLOBAL GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
- TABLE 11 GLOBAL GENOMICS MARKET, BY END USER, $M (2014-2019)
- TABLE 12 GLOBAL GENOMICS MARKET, BY END USER, $M (2020-2030)
- TABLE 13 GLOBAL GENOMICS MARKET, BY REGION, $M (2014-2019)
- TABLE 14 GLOBAL GENOMICS MARKET, BY REGION, $M (2020-2030)
- TABLE 15 NORTH AMERICA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 16 NORTH AMERICA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 17 NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 18 NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 19 NORTH AMERICA GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
- TABLE 20 NORTH AMERICA GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
- TABLE 21 NORTH AMERICA GENOMICS MARKET, BY END USER, $M (2014-2019)
- TABLE 22 NORTH AMERICA GENOMICS MARKET, BY END USER, $M (2020-2030)
- TABLE 23 NORTH AMERICA GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
- TABLE 24 NORTH AMERICA GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
- TABLE 25 U.S. GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 26 U.S. GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 27 U.S. GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 28 U.S. GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 29 CANADA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 30 CANADA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 31 CANADA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 32 CANADA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 33 EUROPE GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 34 EUROPE GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 35 EUROPE GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 36 EUROPE GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 37 EUROPE GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
- TABLE 38 EUROPE GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
- TABLE 39 EUROPE GENOMICS MARKET, BY END USER, $M (2014-2019)
- TABLE 40 EUROPE GENOMICS MARKET, BY END USER, $M (2020-2030)
- TABLE 41 EUROPE GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
- TABLE 42 EUROPE GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
- TABLE 43 U.K. GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 44 U.K. GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 45 U.K. GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 46 U.K. GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 47 GERMANY GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 48 GERMANY GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 49 GERMANY GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 50 GERMANY GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 51 FRANCE GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 52 FRANCE GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 53 FRANCE GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 54 FRANCE GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 55 ITALY GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 56 ITALY GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 57 ITALY GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 58 ITALY GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 59 SPAIN GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 60 SPAIN GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 61 SPAIN GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 62 SPAIN GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 63 APAC GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 64 APAC GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 65 APAC GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 66 APAC GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 67 APAC GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
- TABLE 68 APAC GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
- TABLE 69 APAC GENOMICS MARKET, BY END USER, $M (2014-2019)
- TABLE 70 APAC GENOMICS MARKET, BY END USER, $M (2020-2030)
- TABLE 71 APAC GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
- TABLE 72 APAC GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
- TABLE 73 CHINA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 74 CHINA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 75 CHINA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 76 CHINA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 77 JAPAN GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 78 JAPAN GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 79 JAPAN GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 80 JAPAN GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 81 INDIA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 82 INDIA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 83 INDIA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 84 INDIA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 85 LATAM GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 86 LATAM GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 87 LATAM GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 88 LATAM GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 89 LATAM GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
- TABLE 90 LATAM GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
- TABLE 91 LATAM GENOMICS MARKET, BY END USER, $M (2014-2019)
- TABLE 92 LATAM GENOMICS MARKET, BY END USER, $M (2020-2030)
- TABLE 93 LATAM GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
- TABLE 94 LATAM GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
- TABLE 95 MEA GENOMICS MARKET, BY SOLUTION, $M (2014-2019)
- TABLE 96 MEA GENOMICS MARKET, BY SOLUTION, $M (2020-2030)
- TABLE 97 MEA GENOMICS MARKET, BY TECHNOLOGY, $M (2014-2019)
- TABLE 98 MEA GENOMICS MARKET, BY TECHNOLOGY, $M (2020-2030)
- TABLE 99 MEA GENOMICS MARKET, BY APPLICATION, $M (2014-2019)
- TABLE 100 MEA GENOMICS MARKET, BY APPLICATION, $M (2020-2030)
- TABLE 101 MEA GENOMICS MARKET, BY END USER, $M (2014-2019)
- TABLE 102 MEA GENOMICS MARKET, BY END USER, $M (2020-2030)
- TABLE 103 MEA GENOMICS MARKET, BY COUNTRY, $M (2014-2019)
- TABLE 104 MEA GENOMICS MARKET, BY COUNTRY, $M (2020-2030)
- TABLE 105 LIST OF PLAYERS AND THEIR OFFERINGS
- TABLE 106 COMPETITIVE BENCHMARKING OF KEY PLAYERS
- TABLE 107 BIO-RAD LABORATORIES INC. - AT A GLANCE
- TABLE 108 BIO-RAD LABORATORIES INC. - KEY FINANCIAL SUMMARY
- TABLE 109 AGILENT TECHNOLOGIES INC. - AT A GLANCE
- TABLE 110 AGILENT TECHNOLOGIES INC. - KEY FINANCIAL SUMMARY
- TABLE 111 QUEST DIAGNOSTICS INC. - AT A GLANCE
- TABLE 112 QUEST DIAGNOSTICS INC. - KEY FINANCIAL SUMMARY
- TABLE 113 DANAHER CORPORATION - AT A GLANCE
- TABLE 114 DANAHER CORPORATION - KEY FINANCIAL SUMMARY
- TABLE 115 QIAGEN N.V. - AT A GLANCE
- TABLE 116 QIAGEN N.V. - KEY FINANCIAL SUMMARY
- TABLE 117 F. HOFFMANN-LA ROCHE LTD. - AT A GLANCE
- TABLE 118 F. HOFFMANN-LA ROCHE LTD. - KEY FINANCIAL SUMMARY
- TABLE 119 EUROFINS SCIENTIFIC SE - AT A GLANCE
- TABLE 120 EUROFINS SCIENTIFIC SE - KEY FINANCIAL SUMMARY
- TABLE 121 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - AT A GLANCE
- TABLE 122 PACIFIC BIOSCIENCES OF CALIFORNIA INC. - KEY FINANCIAL SUMMARY
- TABLE 123 GENEWIZ INC. - AT A GLANCE
- TABLE 124 PSOMAGEN INC. - AT A GLANCE
- TABLE 125 BGI TECH SOLUTIONS CO. LTD. - AT A GLANCE
- TABLE 126 OXFORD NANOPORE TECHNOLOGIES LTD. - AT A GLANCE
- TABLE 127 10X GENOMICS INC. - AT A GLANCE
- TABLE 128 10X GENOMICS INC. - KEY FINANCIAL SUMMARY
- TABLE 129 EPPENDORF AG - AT A GLANCE
- TABLE 130 EPPENDORF AG - KEY FINANCIAL SUMMARY
- TABLE 131 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
- TABLE 132 THERMO FISHER SCIENTIFIC INC.- KEY FINANCIAL SUMMARY
- TABLE 133 ILLUMINA INC.- AT A GLANCE
- TABLE 134 ILLUMINA INC.- KEY FINANCIAL SUMMARY
比較リスト
